Fabry nephropathy and the case for adjunctive renal therapy
- PMID: 17699807
- DOI: 10.1681/ASN.2007070783
Fabry nephropathy and the case for adjunctive renal therapy
Comment on
-
Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta.J Am Soc Nephrol. 2007 Sep;18(9):2609-17. doi: 10.1681/ASN.2006121400. Epub 2007 Jul 26. J Am Soc Nephrol. 2007. PMID: 17656478 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
